IL185401A0 - Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetes - Google Patents
Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetesInfo
- Publication number
- IL185401A0 IL185401A0 IL185401A IL18540107A IL185401A0 IL 185401 A0 IL185401 A0 IL 185401A0 IL 185401 A IL185401 A IL 185401A IL 18540107 A IL18540107 A IL 18540107A IL 185401 A0 IL185401 A0 IL 185401A0
- Authority
- IL
- Israel
- Prior art keywords
- rimonabant
- medicaments
- diabetes
- prevention
- preparation
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- JZCPYUJPEARBJL-UHFFFAOYSA-N rimonabant Chemical compound CC=1C(C(=O)NN2CCCCC2)=NN(C=2C(=CC(Cl)=CC=2)Cl)C=1C1=CC=C(Cl)C=C1 JZCPYUJPEARBJL-UHFFFAOYSA-N 0.000 title 1
- 229960003015 rimonabant Drugs 0.000 title 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0501861A FR2882261B1 (en) | 2005-02-21 | 2005-02-21 | USE OF A PYRAZOLE DERIVATIVE FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE PREVENTION AND TREATMENT OF TYPE 2 DIABETES |
FR0504942A FR2882264A1 (en) | 2005-02-21 | 2005-05-12 | Use of rimonabant and N-peperidino-5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethylpyrazole-3-carboxamide, having cannabinoids receptor antagonistic activity, to treat and prevent type-II diabetes |
FR0505228A FR2882265B1 (en) | 2005-02-21 | 2005-05-23 | USE OF A PYRAZOLE DERIVATIVE FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE PREVENTION AND TREATMENT OF TYPE 2 DIABETES. |
PCT/FR2006/000376 WO2006087481A1 (en) | 2005-02-21 | 2006-02-20 | Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
IL185401A0 true IL185401A0 (en) | 2008-08-07 |
Family
ID=36809538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL185401A IL185401A0 (en) | 2005-02-21 | 2007-08-20 | Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetes |
Country Status (10)
Country | Link |
---|---|
JP (1) | JP2008530189A (en) |
BR (1) | BRPI0608183A2 (en) |
CR (1) | CR9293A (en) |
EA (1) | EA011618B1 (en) |
FR (2) | FR2882264A1 (en) |
IL (1) | IL185401A0 (en) |
MA (1) | MA29262B1 (en) |
MX (1) | MX2007009996A (en) |
TN (1) | TNSN07297A1 (en) |
TW (1) | TW200640457A (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2789079B3 (en) * | 1999-02-01 | 2001-03-02 | Sanofi Synthelabo | PYRAZOLECARBOXYLIC ACID DERIVATIVE, ITS PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
US20040122033A1 (en) * | 2002-12-10 | 2004-06-24 | Nargund Ravi P. | Combination therapy for the treatment of obesity |
-
2005
- 2005-05-12 FR FR0504942A patent/FR2882264A1/en not_active Withdrawn
- 2005-05-23 FR FR0505228A patent/FR2882265B1/en not_active Expired - Fee Related
-
2006
- 2006-02-20 MX MX2007009996A patent/MX2007009996A/en not_active Application Discontinuation
- 2006-02-20 TW TW095105631A patent/TW200640457A/en unknown
- 2006-02-20 JP JP2007555669A patent/JP2008530189A/en not_active Withdrawn
- 2006-02-20 EA EA200701781A patent/EA011618B1/en not_active IP Right Cessation
- 2006-02-20 BR BRPI0608183-5A patent/BRPI0608183A2/en not_active IP Right Cessation
-
2007
- 2007-07-31 TN TNP2007000297A patent/TNSN07297A1/en unknown
- 2007-08-07 CR CR9293A patent/CR9293A/en unknown
- 2007-08-20 IL IL185401A patent/IL185401A0/en unknown
- 2007-08-23 MA MA30158A patent/MA29262B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
TW200640457A (en) | 2006-12-01 |
MX2007009996A (en) | 2007-10-10 |
FR2882265A1 (en) | 2006-08-25 |
EA011618B1 (en) | 2009-04-28 |
EA200701781A1 (en) | 2007-12-28 |
CR9293A (en) | 2007-10-01 |
JP2008530189A (en) | 2008-08-07 |
FR2882264A1 (en) | 2006-08-25 |
BRPI0608183A2 (en) | 2009-11-17 |
MA29262B1 (en) | 2008-02-01 |
TNSN07297A1 (en) | 2008-12-31 |
FR2882265B1 (en) | 2009-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL195947A (en) | Fused cyclic compounds and pharmaceutical compositions comprising them for use in the prevention and treatment of diabetes | |
IL178822A (en) | 4-phenylamino-quinazolin-6-yl-amides, pharmaceutical compositions comprising the same and use thereof in the preparation of medicaments for the treatment of proliferative disorders | |
IL231576A (en) | Adamantyl-acetamide derivatives, pharmaceutical compositions comprising same and use thereof in the manufacture of medicaments | |
IL188732A (en) | Use of ibuprofen and famotidine in the preparation of medicaments | |
IL183101A (en) | Use of tetrahydrocannabivarin in the manufacture of medicaments | |
IL181524A (en) | Heterocyclic compounds, pharmaceutical compositions containing them and their use in the manufacture of medicaments | |
IL206296A (en) | Aminopyrazole derivatives, pharmaceutical compositions comprising them and their use in the manufacture of medicaments for prevention or treatment of diseases | |
IL194699A (en) | Tetrahydropteridines, compositions comprising them and use thereof in the preparation of medicaments | |
PL1912650T3 (en) | Use of flibanserin in the treatment of obesity | |
IL206080A0 (en) | Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases | |
EP2091540A4 (en) | Pyrazolyl derivatives with analgesic activity and therefore useful in the treatment or prophylaxis of pain. | |
EP2164490A4 (en) | Pyrazolyl derivatives with analgesic activity and therefore useful in the treatment or prophylaxis of pain. | |
GB0523576D0 (en) | Drug composition and its use in therapy | |
ZA201003037B (en) | Use of 3, 11b-cis-dihydrotettabenazine in the treatment of multiple sclerosis and autoimmune myelitis | |
IL194880A (en) | Aminothiazole derivatives, their use in the treatment of diseases and pharmaceutical compositions comprising them | |
IL178903A0 (en) | Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions | |
IL195441A0 (en) | Use of trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthaleneamine and its formamide in the preparation of medicaments for the treatment of pain disorders | |
ZA200702421B (en) | Iron complex for use in the treatment and/or prevention of nutritional disorders | |
IL184697A (en) | Injectable preparation containing diclofenic, a process for its preparation and use of the preparation in the manufacture of medication for the relief of pain and/or inflammation | |
EP2005964A4 (en) | The medicament for treating hyperphospheremia and preparation thereof | |
IL201426A0 (en) | Drug combination and its use in the treatment of muscle loss | |
EP1757282A4 (en) | The use of kauranes compounds in the manufacture of medicament | |
PL2193789T3 (en) | The application of 3,5-dihydroxytoluene or derivatives thereof in the preparation of medicine and functional food for treating or preventing depression | |
EP1944039A4 (en) | Drug for treating tumor and use thereof in the manufature of medicaments for treating tumor | |
ZA200707012B (en) | Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetes |